Larvol Delta - How-the-Innate-Immune-System-of-the-Blood-Contributes-to-Systemic-Pathology-in-COVID19Induced-ARDS-and-Provides-Potential-Targets-for-Treatment

Firazyr (icatibant) - Takeda

Kalbitor (ecallantide) - Takeda

Soliris (eculizumab) - AstraZeneca

Takhzyro (lanadelumab) - Takeda

AMY-101 - Amyndas

http://www.ncbi.nlm.nih.gov/pubmed/35350780

Mar 31, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next